Alvos Therapeutics' Acquisition

Alvos Therapeutics was acquired by Arrowhead Research on April 12, 2012.

Alvos Therapeutics is a biopharmaceutical provider to use in vivo phage display technology systematically to develop novel cancer drugs. Alvos was founded to translate the research into effective canc…

Articles about Alvos Therapeutics' Acquisition: